AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 38 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity.

AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 38 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity.
Published: 2019-03-01

Get a Quote or Let Us Help You!

If you'd like to explore your insurance options, please visit our contact page or connect with a member of The Richards Group team at (262) 326-4750.

Get a Quote Today!

Enjoy this blog? Please spread the word :)

Facebook
LinkedIn
Twitter
Instagram
YouTube
Pinterest
Follow by Email
Google+
http://richardsgroupinsurance.com/feed-items/aurobindopharma-usa-inc-initiates-a-voluntary-nationwide-consumer-level-recall-expansion-of-38-lots-of-amlodipine-valsartan-tablets-usp-and-valsartan-tablets-usp-due-to-the-detection-of-ndea-n-nit">
RSS
Follow Us on LinkedIn Follow Us on Twitter Subscribe to Us on YouTube Follow Us on Facebook